Skip to main content
. 2021 May 3;21:228. doi: 10.1186/s12903-021-01580-6

Table 3.

Clinicopathological details

Parameters Number (%) Porphyromonas gingivalis P value
Low High
Age (years) 55.8 ± 12.7 95 (100) 55.7 ± 12.6 56.5 ± 14.6 0.860
Gender Male 65 (68.4) 57 8 0.999
Female 30 (31.6) 27 3
Systemic disease No 69 (72.6) 61 8 0.999
Yes 26 (27.4) 23 3
Pathologic staging pStage I + II 69 (72.6) 65 4 0.008
pStage III + IV 26 (27.4) 19 7
Smoking No 45 (47.4) 39 6 0.612
Yes 50 (52.6) 45 5
Alcohol consumption No 57 (60.0) 50 7 0.999
Yes 38 (40.0) 34 4
Location Buccal 21 (24.2) 21 2 0.447
Tongue 52 (54.7) 47 5
Gingiva 11 (11.6) 9 2
Floor of mouth 5 (5.3) 4 1
Hard palate 4 (4.2) 3 1
Differentiation grade Well 17 (19.1) 16 1 0.735
Moderate 65 (73.0) 57 8
Poor 7 (7.9) 6 1
FimA genotypes I + Ib 20 (21.1) 17 3 0.795*
II 30 (31.6) 27 3
III 4 (4.2) 4 0
IV 20 (21.1) 16 4
V 2 (2.1) 2 0
I + Ib + II 1 (1.1) 1 0
I + Ib + III 2 (2.1) 2 0
I + Ib + IV 1 (1.1) 1 0
I + Ib + V 1 (1.1) 1 0
II + IV 3 (3.2) 3 0
I + Ib + II + IV 1 (1.1) 1 0
Untyped 10 (10.5) 9 1
Treatment Surgery 64 (68.1) 60 4
Surgery + RT or CRT** 30 (31.9) 23 7
Outcome Recurrence 24 (25.5) 25 0 0.033
Disease-free 70 (74.5) 58 11
Disease-free time (months) 23, 10 94 (98.9) 22, 13.8 27, 8 0.029

*Chi-square test was used among fimA genotype I + Ib, II, III, IV, V

One patient dropped out in follow-up

**RT: Radiotherapy, CRT: Chemo-radiotherapy